Document Detail

Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
MedLine Citation:
PMID:  23225026     Owner:  NLM     Status:  Publisher    
Oral mucositis (OM) is one of the most common and debilitating complications in patients undergoing intensive chemotherapy followed by hematopoietic stem cell transplantation (HSCT). The aim of this study was to evaluate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) oral spray for OM induced by intensive chemotherapy followed by HSCT. Patients were randomly assigned to either the rhEGF group or placebo group. The severity of OM and self-reported quality of life (QOL) were assessed daily. A total of 58 patients were analyzed. Baseline characteristics were similar between the two groups. The incidence of NCI grade ≥2 OM was higher in the rhEGF group (78.6% vs. 50%, P = 0.0496). However, the duration of OM in patients with NCI grade ≥2 tended to be shorter in the rhEGF group (8.5 days vs. 14.5 days, P = 0.262). The QOL analysis in patients with World Health Organization (WHO) grade ≥3 OM showed that rhEGF significantly reduced limitations in swallowing (P = 0.039) and drinking (P = 0.042). The duration of hospitalization (P = 0.047), administration of total parenteral nutrition (P = 0.012), and the usage of opioid analgesics (P = 0.018) were significantly shorter in the rhEGF group with WHO grade ≥3 OM. Adverse events were mild and similar between the two groups. In conclusion, this analysis showed that rhEGF did not reduce the incidence of NCI grade ≥2 OM. However, the patients with WHO grade ≥3 OM in the rhEGF group showed better results compared to the placebo group for several secondary endpoints. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.
Kyung Im Kim; Ji-Won Kim; Hyun Jung Lee; Byung-Su Kim; Soo-Mee Bang; Inho Kim; Jung Mi Oh; Sung-Soo Yoon; Jong Seok Lee; Seonyang Park; Byoung Kook Kim
Related Documents :
1385676 - A new technique for indirect inguinal hernia repair.
22467926 - Fcgr2a/cd32a and fcgr3a/cd16a variants and eular response to tumor necrosis factor-α b...
18157646 - A long-term evaluation of the modified mesh-plug hernioplasty in over 2,000 patients.
24708156 - Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroi...
24178916 - Bilateral priming accelerates recovery of upper limb function after stroke: a randomize...
25252516 - Assessing two methods of repair of duodenal defects, jeujenal serosal patch and jejunal...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-17
Journal Detail:
Title:  American journal of hematology     Volume:  -     ISSN:  1096-8652     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of isomalt for colon-specific delivery and its comparison with lactulose.
Next Document:  Site-Selective Deuterated-Alkene Synthesis with Palladium on Boron Nitride.